Could corticosteroid use put your patients at a greater risk of metabolic syndrome?
Three highlights of obesity research examined the impact of corticosteroid use on prevalence of metabolic syndrome, explored the effects of a weight management program on job performance, and investigated the consequences of Vitamin D deficiency in overweight and obese children and adolescents.
Associations Between Local Corticosteroid Use, Metabolic Syndrome, and Body Mass Index in a Large Population-Based Cohort Study: the Lifelines Cohort Study. Abstract link.
Compared with nonusers of corticosteroids, the corticosteroid users had a 1.1-fold increased likelihood of metabolic syndrome.
Inhaled corticosteroids may have greater systemic effects than recognized. Strict monitoring, especially in women at risk of metabolic syndrome, is warranted with potentially more restraint in prescriptions of this type of medication.
Impact of a Structured Weight Management Program on Worker Performance. Abstract link.
Obese people who participate in a structured weight loss program report fewer hours missed from work.
Participation in a weight management program may lead to favorable effects on work attendance, which may reflect improvements in co-existing medical illnesses or depression.
Vitamin D Status Is Associated with Early Markers of Cardiovascular Disease in Children and Adolescents with Overweight and Obesity. Abstract link.
Vitamin D deficiency may be an early marker of cardiovascular disease in overweight and obese children and adolescents.